Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
A. John Camm
St. George’s University of London, UK
John Camm is Professor of Clinical Cardiology at St George’s Hospital Medical School, University of London, UK, and Imperial College, London.
Professor Camm’s interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure and cardiomyopathy patients.
Professor Camm graduated from Guy’s Hospital, London and pursued a career in cardiology at St Bartholomew’s Hospital, London, before moving to St George’s in 1986. He was elected Chair of Medicine in October 1990. Professor Camm is a Fellow of the Royal College of Physicians (London, Edinburgh and Glasgow), The Academy of Medical Sciences, the American College of Cardiology, the American Heart Association, the Heart Rhythm Society, the European Society of Cardiology, the European Heart Rhythm Association. He is President of the Arrhythmia Alliance, Founder and Trustee of the Atrial Fibrillation Society, Trustee of the Drug Safety Research Unit, President of the European Heart Rhythm Society, Editor-in-Chief of European Heart Journal – Case Reports and Clinical Cardiology, Editor of the European Heart Journal, editorial board member of a further 15 journals, and Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed.
Professor Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation and the NICE guidelines for the treatment of unstable angina and non-ST elevation ACS. He has authored or co-authored over 1300 papers.
Professor Camm is a recipient of several honours including Queen’s Honorary Physician for his work in setting up and contributing to the medical protection of the Queen and the Royal Family over a period of 25 years, and Commander of the Venerable Order of St. John of Jerusalem for his contribution to teaching and service in the St. John Ambulance Brigade.
Professor Camm is the recipient of the European Society of Cardiology Gold Medal and the British Cardiovascular Society Mackenzie Medal.
The National Institute for Cardiovascular Diseases, Bratislava, Slovakia
Róbert Hatala is Professor of Cardiology and Angiology at the Faculty of Medicine, the National Institue for Cardiovascular Diseases, Bratislava, Slovakia
Since 1995 Róbert has been working as Director of the Arrhythmia and Pacing Centre and since 2008 as head of the Division of Cardiology at the National Cardiovascular Institute and Slovak Medical University in Bratislava, Slovakia. He obtained his MD degree (summa cum laude) in 1980 at the Comenius University School of Medicine in Bratislava, Slovakia, where he was inaugurated in 2001 as full professor of internal medicine – cardiology. During his postgraduate practice he also gained extensive clinical experience of over 5 – years duration at university clinics in Canada (Montreal), Germany (Hamburg), France (Paris) and Austria (Vienna). His main areas of clinical and scientific interest are cardiac arrhythmias with special focus on catheter ablation, all aspects of atrial fibrillation, sudden death and its prevention and arrhythmogenesis in CAD, hypertension and heart failure. In 1995 he founded the first specialized arrhythmia centre in Slovakia, which admits annually over 1,500 patients who undergo more than 2,000 interventions (device implantations and catheter ablations) in adults and children. Róbert authored or co-authored over 60 papers in peer-reviewed journals and more than 200 presentations on major cardiologic meetings. In the years 1997 – 2003 and 2016-18 he was elected for 2 terms President of the Slovak Society of Cardiology.
In 2008 he founded the Slovak Heart Rhythm Association which he chaired until 2014.
During the period 2011 – 2013 he served as member of the Board of the EHRA responsible for National Societies.
Irene Marthe Lang
Medical University of Vienna, Austria
Professor Irene Lang is Head of Cardiac Catheterization Laboratory, Head of the Pulmonary Hypertension Outpatient Clinic at the Medical University of Vienna and Deputy Director of the Clinical Department of Cardiology.
Professor Lang’s basic and clinical research include Thrombosis and Vascular Biology, Pulmonary Hypertension and Coronary Artery Disease and ACS. Her main therapeutic areas are Stable Ischemic Heart Disease, Myocardial Infarction, Pulmonary Hypertension, Thrombosis, Vascular Biology, and Heart Failure.
La Paz University Hospital, Madrid, Spain
Teresa López-Fernández is a clinical investigator and senior consultant cardiologist at La Paz University Hospital in Madrid, Spain. Dr. López-Fernández specializes in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology.
Dr. López-Fernández founded and continues to coordinate the cardio-oncology team at La Paz University Hospital. She is also the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC). She serves as Vice President for the International Cardio-Oncology Society (ICOS) and she is the ESC council of cardio-oncology secretary. Dr. López-Fernández is also regularly invited to speak about cardio-oncology at both national and international conferences.
Her current research interests focus on cardiotoxicity diagnosis and preventive strategies. Dr. López-Fernández has authored over 100 peer-reviewed publications and book chapters.
Department of Internal Medicine and Cardiology, Saarland University Hospital, Homburg, Germany
Dr Felix Mahfoud studied medicine at the Johann-Wolfgang-Goethe University, Frankfurt, Germany. He completed his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany. He is currently associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital and Affiliate/Visiting Professor of the Harvard-MIT, Biomedical Engineering, Boston, MA. Dr Mahfoud has board certifications in internal medicine, cardiology, intensive care medicine, and hypertension. He is a recipient of multiple national and international awards. His special scientific interest includes pathophysiology, conservative and novel interventional therapies of hypertension and heart failure. He is member of several editorial boards and serves as board member of the European Society of Cardiology Council on Hypertension‚ Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension, EuroPCR Board of Directors, Co-Chairmen of the Resistant Hypertension Course, and program committee member of the ESC congress 2017 & 2018. Dr Mahfoud is involved as steering committee member in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.
Royal Brompton Hospital, London, UK
Professor Susanna Price trained in both cardiology and intensive care, and is a consultant cardiologist and intensivist at the Royal Brompton Hospital where she is lead for peri-procedural echocardiography and Severe Acute Cardiac Failure/Cardiogenic shock. She is Professor of cardiology and intensive care medicine (National Heart & Lung Institute) Imperial College London.
Professor Price is a Board member, Councillor and Chair of the Education Committee of the European Society of Cardiology (ESC) and immediate Past-President of the European Society of Cardiology Acute Cardiovascular Care Association (ESC ACVC), and sits on numerous additional ESC Committees well as the ALS subcommittee of the RCUK and SCCM US guideline committee. She is a Deputy Editor of the European Heart Journal, and an invited reviewer for a number of other journals. She has been a member of numerous Task Forces relating to international guidelines & position papers on the management of cardiovascular diseases including valvular disease, endocarditis, non-cardiac surgery, pulmonary hypertension, pericardial disease, cardiovascular disease in pregnancy and grown-up congenital heart disease, as well as ECMO, and echocardiography in the intensive care setting. She has authored numerous papers and book chapters on cardiology, echocardiography and intensive care, and lectures regularly globally.
Clinical Associate, Cardiologicum, Stuttgart, Germany
Present Position and Address:
-Clinical Associate, Cardiologicum, Rosenbergstr. 19, 70176 Stuttgart
-Project Coordinator for Research, Division of Cardiology, Department of Internal Medicine, Robert‐Bosch‐Krankenhaus Stuttgart
-Associate Professor of Medicine and Cardiology, University of Tübingen
Training and Education:
1969‐1975: Electrical engineering studies at TU Hannover, Diploma
1975, academic title “DiplomIngenieur”
1975‐1979: Medical studies, Medizinische Hochschule Hannover
1980‐1981: Medical studies, University of Köln
10/81: State graduation examination in Medicine
Post Graduate Degrees:
1983: Academic title “Dr. med.” with a thesis entitled “Long term results after gastrectomy”. This work was done at the Department of Abdominal‐ and Transplant‐Surgery (Director: Prof. Dr. Pichlmaier), Med. Hochschule Hannover.
12/88: Board examination in Internal Medicine
10/89: Habilitation for Internal Medicine. Thesis: “Evaluation of cardiac function using magnetic resonance imaging”, academic title “Privatdozent”
6/90: Board examination in Cardiology
European Society of Cardiology Activities:
1994‐2000: Member and later Chairman of the Executive Scientific Committee of the ESC
2000‐2004: Member of the Board and the Management Group of the ESC
2006‐2012: Member of the Committee for Practice Guidelines of the ESC
Since 2008: Editorial Board Member European Heart Journal and Associate Editor
2016‐2018: Member of the Media Committee of the ESC
2018‐2020: Member Executive Scientific Committee of the ESC
Since 2018: Member of the DOI Task Force of the ESC
Other International Scientific Committee Participation:
Since 1986: American Heart Association, Council on Cardiovascular Radiology and Clinical Cardiology
Since 1988: Member of the German Cardiac Society
Since 1989: Working Group “Nuclear Cardiology”, German Cardiac Society, Chairman 1993‐1995
Since 1993: Member Working Group “Congenital Heart Disease in Adolescents and Adults”, German Cardiac Society
1995‐1998: Founding chairman of the Working Group “Magnetic Resonance Techniques in Cardiovascular Disease” of the German Cardiac Society
2005‐2007: President, Association of Chiefs of Cardiology Departments in German Hospitals (ALKK)
2005‐2007: Associate Member, Board German Cardiac Society
2007‐2009: Member Commission Clinical Cardiology, German Cardiac Society
2009‐2011: Chairman, Commission Clinical Cardiology German Cardiac Society
2009‐2011: Member, Board German Cardiac Society
2009‐2012: Vice Chairman, German Foundation for Heart Research
2012‐2022: Chairman, German Foundation for Heart Research
European Heart Journal Cardiovascular Imaging
Clinical Research Cardiology
European Heart Journal (Associate Editor)
European Heart Journal ‐ Cardiovascular Pharmacotherapy
International Journal of Cardiology
European Heart Journal ‐ Acute Cardiovascular Care
St George’s University of London and St George’s NHS Foundation trust, London, UK
Sanjay Sharma is Professor of cardiology and head of research for the clinical academic group at St George’s University of London and St George’s NHS Foundation trust. His research interests include sudden cardiac death in the young, heart muscle disease and cardiovascular adaptation in athletes. He is considered a world leader in sports cardiology for which he has a large scientific programme culminating in over almost 500 publications (including over 320 on PubMed and authorship of numerous textbooks). He has supervised several MD (Res) and PhD degrees in cardiology and regularly lectures at major scientific meetings.
Professor Sharma leads a large tertiary inherited cardiac diseases programme serving South East England to manage young patients with cardiomyopathy and ion channel diseases. He is the director for the largest sports cardiology unit in the UK which is responsible for athletes with potentially serious cardiac diseases including amateurs but also professionals from a number of sporting organizations including the English Football Association, rugby league, Lawn Tennis Association, English Institute of Sport, Team GB Rowing and Team Sky cycling. He is the medical director of the London marathon and has been commended for providing one of the best medical services for endurance events in the world. Professor Sharma is also the chairman of the expert cardiology consensus panel for the English Football Association and for the 2012 London Olympics, he was appointed lead cardiologist. Until recently, he was chairman of the ESC sports cardiology nucleus and congress programme committee member of the European Society of Cardiology and the European Association of Preventive Cardiology.
Working with the charitable organisation, Cardiac Risk in the Young (CRY) for the past 20 years, Professor Sharma leads the largest cardiac screening programme in the UK for individuals aged 14-35 years old. The charity screens over 20,000 individuals each year from which several data sets have been developed to provide an estimate of the number of young individuals dying suddenly from unsuspected heart disease and offer strategies to prevent such tragedies. His role in promoting the detection of cardiac disease in the young has been recognised within the British government where he gives an annual address at the CRY Parliamentary Meeting.
Professor Sharma leads a large research group based at St.George’s, University of London and the publications generated from his expertise have helped further our understanding of the athlete’s heart on a global scale. Not only has he contributed to European scientific position statements and recommendations for sporting participation in athletes with cardiac disease, but he was lead author of the international recommendations for the interpretation of the athlete’s ECG that were co-published in EHJ and JACC in 2017. His reputation as a world-renowned leader in this subject has most recently been highlighted by reporting the outcomes of screening adolescent athletes in NEJM, which has helped shape screening policies of sporting organizations in the UK and beyond.
David A. Wood
National Institute for Prevention and Cardiovascular Health, National University of Ireland – Galway, Ireland
Professor David A. Wood is a cardiologist with a special interest in prevention of cardiovascular disease. He has contributed to international policy and guidelines on cardiovascular disease (CVD) prevention through the World Health Organisation, World Heart Federation and the European Society of Cardiology. He was a founder and President of the European Association for Cardiovascular Prevention and Rehabilitation, a Board member and Secretary/Treasurer of the European Society of Cardiology and President of the World Heart Federation.
He is jointly appointed between Imperial College as Emeritus Professor of Cardiology and Adjunct Professor of Preventive Cardiology at the National Institute of Prevention and Cardiovascular Health (NIPC), National University of Ireland-Galway, Republic of Ireland.